Ifosfamide

colony stimulating factor 3 ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27568305 Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR). 2017 Jan 1
2 31149423 Dramatic response of chemotherapy for cancer of unknown primary origin of sarcomatoid carcinoma producing granulocyte colony-stimulating factor. 2016 Jan 1
3 24625457 Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience. 2014 Aug 1
4 25060582 First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era. 2013 2
5 18806833 EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells. 2009 Feb 1
6 12872353 High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma. 2003 Jul 15 1
7 12373597 Phase I study of docetaxel plus ifosfamide in patients with advanced cancer. 2002 Oct 7 1
8 11753545 Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma. 2001 Nov 1
9 10100555 Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer. 1999 Mar 1
10 10378632 A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor. 1999 1
11 10465132 Cd 34+ cells and clonogenicity of peripheral blood stem cells during chemotherapy treatment in association with granulocyte colony stimulating factor in osteosarcoma. 1999 Aug 2
12 10572602 Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clinique de l'Université Catholique de Louvain, Brussels and Liège, Belgium. 1999 Sep 1
13 18521274 Evaluation of dose-intense Ifosfamide, with and without edatrexate, in adults with sarcoma. 1999 1
14 9535207 Ifosfamide-based three-drug combination regimens in non-small cell lung cancer. 1998 Feb 1
15 9106021 Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer. 1997 Feb 1
16 9317171 A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. 1997 Oct 1 1
17 8677441 Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies. 1996 Jun 1
18 8946866 Prophylactic granulocyte colony-stimulating factor allows escalation of chemotherapeutic dose intensity in advanced epithelial ovarian cancer. 1996 Dec 1
19 7533518 The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer. 1995 Mar 1
20 8583722 [Gingival metastasis of large-cell lung cancer that produced G-CSF]. 1995 Nov 1
21 9815972 A phase I study of ifosfamide and doxorubicin with recombinant human granulocyte colony-stimulating factor in stage IV breast cancer. 1995 Feb 1
22 7692928 Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin. 1993 Jul 1
23 1329215 Novel approaches with ifosfamide in small cell lung cancer. 1992 Feb 1